Flovaxin-500

  • Broad spectrum antibacterial agent with activity against a wide range of Gram-positive and Gram-negative bacteria and a typical organisms
  • High microbiological eradication rates, ranging from 79.8% to 95.3%
  • Shows overall response rate 86% in treatment of acute exacerbation of chronic bronchitis
  • Offers combination of documented efficacy and tolerability

A powerful fluoroquinolone antibiotic that treats difficult infections like pneumonia, bronchitis, prostatitis, and urinary infections. Known for high bacterial eradication rates and fast symptom recovery.

Additional information